Structure of a germline-like human antibody defines a neutralizing epitope on the SARS-CoV-2 spike NTD
Clara G. Altomare(Icahn School of Medicine at Mount Sinai), Goran Bajic(Icahn School of Medicine at Mount Sinai), Juan Manuel Carreño(Icahn School of Medicine at Mount Sinai), Ali H. Ellebedy(Washington University in St. Louis), Iden A. Sapse(Icahn School of Medicine at Mount Sinai), Fatima Amanat(Icahn School of Medicine at Mount Sinai), Florian Krammer(Semmelweis University), Viviana Simon(Icahn School of Medicine at Mount Sinai), Daniel C. Adelsberg(Icahn School of Medicine at Mount Sinai)
Cited by 1
Related Papers
Influenza
|Nature Reviews Disease Primers|2018|1.5k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
|New England Journal of Medicine|2021|803